135 related articles for article (PubMed ID: 36239795)
21. Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.
Shigeta S; Nagase S; Mikami M; Ikeda M; Shida M; Sakaguchi I; Ushioda N; Takahashi F; Yamagami W; Yaegashi N; Udagawa Y; Katabuchi H
J Gynecol Oncol; 2017 Nov; 28(6):e76. PubMed ID: 29027394
[TBL] [Abstract][Full Text] [Related]
22. Metformin is associated with improved survival in endometrial cancer.
Ko EM; Walter P; Jackson A; Clark L; Franasiak J; Bolac C; Havrilesky LJ; Secord AA; Moore DT; Gehrig PA; Bae-Jump V
Gynecol Oncol; 2014 Feb; 132(2):438-42. PubMed ID: 24269517
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
24. Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer - a population-based study.
Scharl S; Gerken M; Sprötge T; Kronberger K; Scharl A; Ignatov A; Ortmann O; Kölbl O; Klinkhammer-Schalke M; Papathemelis T
Acta Oncol; 2021 Jul; 60(7):897-903. PubMed ID: 33905297
[TBL] [Abstract][Full Text] [Related]
25. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
26. Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry.
Wimmer T; Ortmann O; Gerken M; Klinkhammer-Schalke M; Koelbl O; Inwald EC
Arch Gynecol Obstet; 2019 Apr; 299(4):1131-1140. PubMed ID: 30607594
[TBL] [Abstract][Full Text] [Related]
27. SATEN III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an international, multicenter study.
Kahramanoglu I; Meydanli MM; Taranenka S; Ayhan A; Salman C; Sanci M; Demirkiran F; Ortac F; Haidopoulos D; Sukhin V; Kaidarova D; Stepanyan A; Farazaneh F; Aliyev S; Ulrikh E; Kurdiani D; Yalcin İ; Mavrichev S; Akilli H; Sarı ME; Pletnev A; Aslan K; Bese T; Kairbayev M; Vlachos D; Gultekin M
Int J Gynecol Cancer; 2019 Oct; 29(8):1271-1279. PubMed ID: 31481453
[TBL] [Abstract][Full Text] [Related]
28. Adjuvant Chemotherapy versus Radiotherapy in High-risk, Early-stage Endometrioid Endometrial Carcinoma.
Wu M; Yang YN; Huang YH; Cai J; He XQ; Wang ZH
Curr Med Sci; 2022 Feb; 42(1):185-191. PubMed ID: 34669113
[TBL] [Abstract][Full Text] [Related]
29. Predictors of Survival in Women with High-Risk Endometrial Cancer and Comparisons of Sandwich versus Concurrent Adjuvant Chemotherapy and Radiotherapy.
Chen HH; Ting WH; Sun HD; Wei MC; Lin HH; Hsiao SM
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32824293
[No Abstract] [Full Text] [Related]
30. The efficacy of adjuvant chemotherapy on the survival of early stage endometrial cancer.
Yoneoka Y; Amano T; Tsuji S; Uno M; Ishikawa M; Kato T; Murakami T
Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():155-160. PubMed ID: 37343413
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant Radiation Field Extent and Sites of Failure in Node Positive Endometrioid Endometrial Cancer.
Yerramilli D; Chen YH; Venkatachalam V; Alban GM; Buscariollo DL; Cheng T; King MT; Pretz JL; Russo AL; Lee LJ
Pract Radiat Oncol; 2021; 11(5):394-403. PubMed ID: 34015544
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study.
Albuquerque K; Folkert M; Mayadev J; Christie A; Liotta MR; Nagel C; Sevak P; Harkenrider MM; Lea JS; Hanna RK; Small WC; Miller DS; Xie XJ; Potkul RK; Elshaikh MA
Am J Clin Oncol; 2018 Aug; 41(8):792-796. PubMed ID: 28225446
[TBL] [Abstract][Full Text] [Related]
33. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger PB; Ledermann JA; Khaw P; D'Amico R; Fyles A; Baron MH; Jürgenliemk-Schulz IM; Kitchener HC; Nijman HW; Wilson G; Brooks S; Gribaudo S; Provencher D; Hanzen C; Kruitwagen RF; Smit VTHBM; Singh N; Do V; Lissoni A; Nout RA; Feeney A; Verhoeven-Adema KW; Putter H; Creutzberg CL;
Lancet Oncol; 2019 Sep; 20(9):1273-1285. PubMed ID: 31345626
[TBL] [Abstract][Full Text] [Related]
35. A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17).
Yoon MS; Park W; Huh SJ; Kim HJ; Kim YS; Kim YB; Kim JY; Lee JH; Kim HJ; Cha J; Kim JH; Kim J; Yoon WS; Choi JH; Chun M; Choi Y; Chang SK; Lee KK; Kim M
Gynecol Oncol; 2015 Sep; 138(3):519-25. PubMed ID: 26115977
[TBL] [Abstract][Full Text] [Related]
36. Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) - Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative Care, Psycho-oncological/Psychosocial Care/Rehabilitation/Patient Information and Healthcare Facilities.
Emons G; Steiner E; Vordermark D; Uleer C; Bock N; Paradies K; Ortmann O; Aretz S; Mallmann P; Kurzeder C; Hagen V; van Oorschot B; Höcht S; Feyer P; Egerer G; Friedrich M; Cremer W; Prott FJ; Horn LC; Prömpeler H; Langrehr J; Leinung S; Beckmann MW; Kimmig R; Letsch A; Reinhardt M; Alt-Epping B; Kiesel L; Menke J; Gebhardt M; Steinke-Lange V; Rahner N; Lichtenegger W; Zeimet A; Hanf V; Weis J; Mueller M; Henscher U; Schmutzler RK; Meindl A; Hilpert F; Panke JE; Strnad V; Niehues C; Dauelsberg T; Niehoff P; Mayr D; Grab D; Kreißl M; Witteler R; Schorsch A; Mustea A; Petru E; Hübner J; Rose AD; Wight E; Tholen R; Bauerschmitz GJ; Fleisch M; Juhasz-Boess I; Lax S; Runnebaum I; Tempfer C; Nothacker MJ; Blödt S; Follmann M; Langer T; Raatz H; Wesselmann S; Erdogan S
Geburtshilfe Frauenheilkd; 2018 Nov; 78(11):1089-1109. PubMed ID: 30581199
[No Abstract] [Full Text] [Related]
37. Postoperative Adjuvant Chemoradiotherapy Versus Chemotherapy Alone for Stage III Endometrial Cancer: A Multicenter Retrospective Study.
Yoo JG; Kim JH; Kim CJ; Lee HN; Song MJ; Park DC; Yoon JH; Kim SI; Hur SY; Lee SJ
Cancer Control; 2022; 29():10732748221115288. PubMed ID: 35848426
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy and radiation for patients with high-risk stage I endometrial cancer treated with curative intent surgery: impact on recurrence and survival.
Findley R; Kooy J; Lester B; Le ND; Bowering G; Rugayan C; Kumar A; Glaze S; Ko J
Int J Gynecol Cancer; 2022 Apr; 32(4):508-516. PubMed ID: 35078828
[TBL] [Abstract][Full Text] [Related]
39. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.
Hogberg T; Signorelli M; de Oliveira CF; Fossati R; Lissoni AA; Sorbe B; Andersson H; Grenman S; Lundgren C; Rosenberg P; Boman K; Tholander B; Scambia G; Reed N; Cormio G; Tognon G; Clarke J; Sawicki T; Zola P; Kristensen G
Eur J Cancer; 2010 Sep; 46(13):2422-31. PubMed ID: 20619634
[TBL] [Abstract][Full Text] [Related]
40. Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group.
Reboux PA; Azaïs H; Canova CH; Bendifallah S; Ouldamer L; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Lévêque J; Lavoué V; Koskas M; Uzan C; Canlorbe G
J Gynecol Oncol; 2019 Jul; 30(4):e53. PubMed ID: 31074238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
